Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quaker Chemical (KWR) Gains from Investment Securities (2016 - 2025)

Quaker Chemical (KWR) has disclosed Gains from Investment Securities for 16 consecutive years, with -$5.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 717.53% to -$5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.0 million, a 464.32% decrease, with the full-year FY2025 number at -$3.0 million, down 464.32% from a year prior.
  • Gains from Investment Securities was -$5.0 million for Q4 2025 at Quaker Chemical, down from -$57000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.1 million in Q1 2021 to a low of -$5.0 million in Q4 2025.
  • A 5-year average of $1.0 million and a median of $810000.0 in 2024 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 67689.95% in 2023, then plummeted 717.53% in 2025.
  • Quaker Chemical's Gains from Investment Securities stood at $1.4 million in 2021, then skyrocketed by 85.16% to $2.6 million in 2022, then skyrocketed by 40.51% to $3.7 million in 2023, then plummeted by 77.89% to $810000.0 in 2024, then tumbled by 717.53% to -$5.0 million in 2025.
  • Per Business Quant, the three most recent readings for KWR's Gains from Investment Securities are -$5.0 million (Q4 2025), -$57000.0 (Q3 2025), and -$40000.0 (Q2 2025).